• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用反相高效液相色谱法快速测定血浆和血清中的吉西他滨。

Rapid determination of gemcitabine in plasma and serum using reversed-phase HPLC.

作者信息

Lanz Christian, Früh Martin, Thormann Wolfgang, Cerny Thomas, Lauterburg Bernhard H

机构信息

Departement für Innere Medizin, Fachbereich Onkologie/Hämatologie, Kantonsspital St. Gallen, Switzerland.

出版信息

J Sep Sci. 2007 Aug;30(12):1811-20. doi: 10.1002/jssc.200600534.

DOI:10.1002/jssc.200600534
PMID:17638352
Abstract

Gemcitabine (2'2'-difluorodeoxycytidine) is a pyrimidine analog used in the treatment of a variety of solid tumors. After intravenous (i.v.) administration, it is rapidly inactivated to 2'-deoxy-2',2'-difluorouridine (dFdU). A sensitive analytical method for the quantitation of gemcitabine is required for the assessment of alternative dosage and treatment schemes. A rapid and robust RP-HPLC assay for analysis of gemcitabine in human and animal plasma and serum was developed and validated using 2'-deoxyuridine (dU) and 5-fluoro-2'-deoxyuridine (5FdU) as internal standards. It is based on protein precipitation, the use of an Atlantis dC18 column of 100 mm length (inner diameter, 4.6 mm; particle size, 3 microm) and isocratic elution using a 10 mM phosphate buffer, pH 3.0, followed by isocratic elution with the same buffer containing 3% of ACN. For gemcitabine, RSD values for intraday and interday precision were < 4.4 and 5.3%, respectively, the LOQ was 20 ng/mL, and the assay was linear in the range of 0.020-20 microg/mL with an accuracy of > or =89%. The recovery for gemcitabine, dU and 5FdU was 86-98%. The assay was applied to determine gemcitabine levels in plasma samples of patients collected during and shortly after conventional infusion of 25-30 mg/kg body mass (levels: 2.0-18.9 microg/mL) and rats that received lower doses (1.5 mg/kg) via i.v., subcutaneous and oral drug administration (levels: 0.20-2.60 microg/mL). It could also be applied to estimate dFdU levels in human plasma.

摘要

吉西他滨(2'2'-二氟脱氧胞苷)是一种用于治疗多种实体瘤的嘧啶类似物。静脉注射后,它会迅速失活为2'-脱氧-2',2'-二氟尿苷(dFdU)。为了评估替代剂量和治疗方案,需要一种灵敏的分析方法来定量吉西他滨。采用2'-脱氧尿苷(dU)和5-氟-2'-脱氧尿苷(5FdU)作为内标,开发并验证了一种快速、稳健的反相高效液相色谱法(RP-HPLC),用于分析人和动物血浆及血清中的吉西他滨。该方法基于蛋白质沉淀,使用100 mm长(内径4.6 mm;粒径3微米)的Atlantis dC18柱,先用10 mM pH 3.0的磷酸盐缓冲液等度洗脱,然后用含3%乙腈的相同缓冲液等度洗脱。对于吉西他滨,日内和日间精密度的相对标准偏差(RSD)值分别<4.4%和5.3%,定量限(LOQ)为20 ng/mL,该方法在0.020 - 20 μg/mL范围内呈线性,准确度≥89%。吉西他滨、dU和5FdU的回收率为86 - 98%。该方法用于测定常规输注25 - 30 mg/kg体重期间及之后不久收集的患者血浆样本中的吉西他滨水平(水平:2.0 - 18.9 μg/mL),以及通过静脉注射、皮下注射和口服给药接受较低剂量(1.5 mg/kg)的大鼠血浆中的吉西他滨水平(水平:0.20 - 2.60 μg/mL)。它还可用于估计人血浆中的dFdU水平。

相似文献

1
Rapid determination of gemcitabine in plasma and serum using reversed-phase HPLC.使用反相高效液相色谱法快速测定血浆和血清中的吉西他滨。
J Sep Sci. 2007 Aug;30(12):1811-20. doi: 10.1002/jssc.200600534.
2
An expedient assay for determination of gemcitabine and its metabolite in human plasma using isocratic ion-pair reversed-phase high-performance liquid chromatography.一种采用等度离子对反相高效液相色谱法测定人血浆中吉西他滨及其代谢物的简便分析方法。
Ther Drug Monit. 2003 Oct;25(5):552-7. doi: 10.1097/00007691-200310000-00003.
3
Determination of gemcitabine and its metabolite in extracellular fluid of rat brain tumor by ultra performance liquid chromatography-tandem mass spectrometry using microdialysis sampling after intralesional chemotherapy.经瘤内化疗后微透析采样的超高效液相色谱-串联质谱法测定大鼠脑肿瘤细胞外液中吉西他滨及其代谢物
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Mar 1;919-920:10-9. doi: 10.1016/j.jchromb.2012.12.027. Epub 2013 Jan 9.
4
Determination of gemcitabine and its metabolite in human plasma using high-pressure liquid chromatography coupled with a diode array detector.采用高压液相色谱-二极管阵列检测器法测定人血浆中吉西他滨及其代谢产物。
Acta Pharmacol Sin. 2004 Dec;25(12):1584-9.
5
Simultaneous determination of gemcitabine and its main metabolite, dFdU, in plasma of patients with advanced non-small-cell lung cancer by high-performance liquid chromatography-tandem mass spectrometry.采用高效液相色谱-串联质谱法同时测定晚期非小细胞肺癌患者血浆中吉西他滨及其主要代谢产物2'-脱氧氟尿苷(dFdU)。
J Mass Spectrom. 2008 Feb;43(2):216-23. doi: 10.1002/jms.1293.
6
Measurement of the anti-cancer agent gemcitabine in human plasma by high-performance liquid chromatography.采用高效液相色谱法测定人血浆中抗癌药物吉西他滨的含量。
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Feb 25;785(1):65-72. doi: 10.1016/s1570-0232(02)00859-0.
7
Simultaneous determination of gemcitabine di- and triphosphate in human blood mononuclear and cancer cells by RP-HPLC and UV detection.采用反相高效液相色谱法和紫外检测法同时测定人血单核细胞和癌细胞中的吉西他滨二磷酸酯和三磷酸酯。
J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Aug 7;840(1):44-9. doi: 10.1016/j.jchromb.2006.04.036. Epub 2006 May 24.
8
Measurement of the anticancer agent gemcitabine and its deaminated metabolite at low concentrations in human plasma by liquid chromatography-mass spectrometry.采用液相色谱-质谱联用技术测定人血浆中低浓度抗癌药物吉西他滨及其脱氨基代谢产物。
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Apr 5;802(2):263-70. doi: 10.1016/j.jchromb.2003.11.038.
9
Validated assay for the simultaneous determination of the anti-cancer agent gemcitabine and its metabolite 2',2'-difluorodeoxyuridine in human plasma by high-performance liquid chromatography with tandem mass spectrometry.通过高效液相色谱-串联质谱法同时测定人血浆中抗癌药物吉西他滨及其代谢物2',2'-二氟脱氧尿苷的验证分析方法。
Rapid Commun Mass Spectrom. 2007;21(14):2312-22. doi: 10.1002/rcm.3096.
10
High-performance liquid chromatographic method for the determination of gemcitabine and 2',2'-difluorodeoxyuridine in plasma and tissue culture media.高效液相色谱法测定血浆和组织培养基中的吉西他滨和2',2'-二氟脱氧尿苷。
J Chromatogr B Analyt Technol Biomed Life Sci. 2006 May 1;835(1-2):136-42. doi: 10.1016/j.jchromb.2006.03.023. Epub 2006 Apr 11.

引用本文的文献

1
Development and Validation of a Simple and Reliable HPLC-UV Method for Determining Gemcitabine Levels: Application in Pharmacokinetic Analysis.开发并验证了一种简单可靠的 HPLC-UV 方法,用于测定吉西他滨的浓度:在药代动力学分析中的应用。
Medicina (Kaunas). 2024 May 25;60(6):864. doi: 10.3390/medicina60060864.
2
Development and validation of simultaneous quantification method for gemcitabine and betulinic acid: augmenting industrial application.吉西他滨和桦木酸同步定量方法的开发与验证:拓展工业应用
3 Biotech. 2023 Aug;13(8):267. doi: 10.1007/s13205-023-03668-y. Epub 2023 Jul 8.
3
Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer.
新型吉西他滨类似物在胰腺癌患者来源异种移植模型中的生物学评价。
BMC Cancer. 2023 May 13;23(1):435. doi: 10.1186/s12885-023-10928-w.
4
CD34 progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg mice.CD34 祖细胞衍生的自然杀伤细胞与吉西他滨联合治疗可增强 NOD/SCID/IL2Rg 小鼠对卵巢癌细胞的杀伤作用。
Oncoimmunology. 2021 Oct 1;10(1):1981049. doi: 10.1080/2162402X.2021.1981049. eCollection 2021.
5
Poly(anhydride-ester) gemcitabine: Synthesis and particle engineering of a high payload hydrolysable polymeric drug for cancer therapy.聚(酸酐-酯)吉西他滨:用于癌症治疗的高载药可水解聚合物药物的合成与粒子工程。
J Control Release. 2021 Feb 10;330:1178-1190. doi: 10.1016/j.jconrel.2020.11.025. Epub 2020 Nov 17.
6
Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models.增强吉西他滨在胰腺癌患者来源的异种移植小鼠模型中的疗效。
Int J Pharm X. 2020 Sep 23;2:100056. doi: 10.1016/j.ijpx.2020.100056. eCollection 2020 Dec.
7
Cytotoxic effects of gemcitabine-loaded solid lipid nanoparticles in pancreatic cancer cells.载吉西他滨固体脂质纳米粒对胰腺癌细胞的细胞毒性作用
J Drug Deliv Sci Technol. 2020 Feb;55. doi: 10.1016/j.jddst.2019.101374. Epub 2019 Nov 8.
8
Concentration changes in gemcitabine and its metabolites after hyperthermia in pancreatic cancer cells assessed using RP-HPLC.使用反相高效液相色谱法评估胰腺癌细胞高温治疗后吉西他滨及其代谢物浓度的变化。
Cell Mol Biol Lett. 2019 May 16;24:30. doi: 10.1186/s11658-019-0153-1. eCollection 2019.
9
Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imaging.用于有效实体瘤治疗和体内成像的智能热敏脂质体。
PLoS One. 2017 Sep 21;12(9):e0185116. doi: 10.1371/journal.pone.0185116. eCollection 2017.
10
Rapid Homogeneous Immunoassay to Quantify Gemcitabine in Plasma for Therapeutic Drug Monitoring.用于治疗药物监测的血浆中吉西他滨定量快速均相免疫测定法。
Ther Drug Monit. 2017 Jun;39(3):235-242. doi: 10.1097/FTD.0000000000000402.